Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 USD | -7.73% | -4.28% | -81.75% |
Financials (USD)
Sales 2024 * | 182M | Sales 2025 * | 247M | Capitalization | 488M |
---|---|---|---|---|---|
Net income 2024 * | -248M | Net income 2025 * | -201M | EV / Sales 2024 * | 5.06 x |
Net Debt 2024 * | 434M | Net Debt 2025 * | 469M | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
-1.93
x | P/E ratio 2025 * |
-2.5
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.13% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | -7.73% | ||
1 week | -4.28% | ||
1 month | +5.92% | ||
3 months | -65.51% | ||
6 months | -79.84% | ||
Current year | -81.75% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.79 | -7.73% | 8,072,866 |
24-05-30 | 1.94 | +6.59% | 6,021,134 |
24-05-29 | 1.82 | -2.93% | 7,535,344 |
24-05-28 | 1.875 | +0.27% | 5,823,942 |
24-05-24 | 1.87 | -3.61% | 8,742,353 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.75% | 488M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- PACB Stock